Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma

Abstract Lung adenocarcinoma (LUAD) is a malignant tumor in the respiratory system. The efficacy of current treatment modalities varies greatly, and individualization is evident. Therefore, finding biomarkers for predicting treatment prognosis and providing reference and guidance for formulating tre...

Full description

Bibliographic Details
Main Authors: Xiang Zhou, Ran Xu, Tong Lu, Chenghao Wang, Xiaoyan Chang, Bo Peng, Zhiping Shen, Lingqi Yao, Kaiyu Wang, Chengyu Xu, Jiaxin Shi, Ren Zhang, Jiaying Zhao, Linyou Zhang
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-40592-w

Internet

https://doi.org/10.1038/s41598-023-40592-w

Similar Items